Enable JavaScript to visit this website.


XELJANZ/XELJANZ XR (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with moderately to severely active rheumatoid arthritis in whom methotrexate did not work well.
  • Adults with active psoriatic arthritis in whom methotrexate or other similar medicines called nonbiologic disease-modifying antirheumatic drugs (DMARDs) did not work well.

XELJANZ is also used to treat:

  • Adults with moderately to severely active ulcerative colitis.

It is not known if XELJANZ/XELJANZ XR is safe and effective in children or in people with hepatitis B or C.

XELJANZ/XELJANZ XR is not recommended for people with severe liver problems.

What do I do if my claim for XELJANZ is denied?

If your request is denied, you may be able to appeal the decision. Call XELSOURCE for help navigating the approval process and to learn more about the support programs that may be available to you.

To speak with a XELSOURCE specialist, call 1-844-XELJANZ (1-844-935-5269), Monday through Friday, 8:00 am–8:00 pm ET, and say “Representative.”